Get the Stockscreener App
29.54
4.20%
-1.295
Tectonic Therapeutic Inc stock is traded at $29.54, with a volume of 316.33K.
It is down -4.20% in the last 24 hours and down -28.61% over the past month.
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease.
See More
Previous Close:
$30.84
Open:
$30.75
24h Volume:
316.33K
Relative Volume:
1.16
Market Cap:
$544.78M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-16.95%
1M Performance:
-28.61%
6M Performance:
+81.78%
1Y Performance:
+0.00%
1-Day Range:
$29.32
$31.12
1-Week Range:
$29.32
$35.44
52-Week Range:
$15.00
$61.07
Tectonic Therapeutic Inc Stock (TECX) Company Profile
Name
Tectonic Therapeutic Inc
Sector
Industry
Phone
(339) 666-3320
Address
490 ARSENAL WAY, WATERTOWN
Compare TECX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TECX
Tectonic Therapeutic Inc
|
29.54 | 544.78M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.24 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
700.33 | 76.56B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
644.48 | 39.16B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
250.59 | 32.44B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
120.01 | 28.77B | 3.30B | -501.07M | 1.03B | -2.1146 |
Tectonic Therapeutic Inc Stock (TECX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-20-24 | Initiated | Raymond James | Outperform |
| Aug-22-24 | Initiated | Wells Fargo | Overweight |
| Jun-26-24 | Initiated | Piper Sandler | Overweight |
| Jun-24-24 | Initiated | TD Cowen | Buy |
| Dec-18-23 | Downgrade | Mizuho | Buy → Neutral |
| Jan-05-22 | Downgrade | BTIG Research | Buy → Neutral |
| Nov-19-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jun-15-21 | Initiated | BTIG Research | Buy |
| May-27-21 | Initiated | Needham | Buy |
| Mar-09-21 | Initiated | Barclays | Overweight |
| Mar-02-21 | Initiated | Stifel | Hold |
| Nov-11-20 | Initiated | Berenberg | Buy |
| Mar-31-20 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jun-27-19 | Initiated | Mizuho | Buy |
| Apr-05-19 | Initiated | Janney | Buy |
| Oct-10-18 | Initiated | Guggenheim | Buy |
| Oct-02-18 | Reiterated | H.C. Wainwright | Buy |
| Sep-17-18 | Initiated | H.C. Wainwright | Buy |
| Jul-16-18 | Initiated | Wedbush | Outperform |
| Jul-16-18 | Initiated | Wells Fargo | Outperform |
View All
Tectonic Therapeutic Inc Stock (TECX) Latest News
Tectonic Therapeutic, Inc. (TECX): Among the Most Expensive Stocks Insiders Are Buying Recently - Insider Monkey
11 Most Expensive Stocks Insiders Are Buying Recently - Insider Monkey
Tectonic Therapeutic to Participate in March Investor Conferences - The Manila Times
Exclusive Access: Tectonic's Management Team Opens Door to Investors at Major March Conferences - StockTitan
Tectonic Therapeutic (NASDAQ:TECX) Sees Significant Growth in Short Interest - MarketBeat
Analyzing Fresh Tracks Therapeutics (NASDAQ:FRTX) and Tectonic Therapeutic (NASDAQ:TECX) - Defense World
Tectonic jumps on positive data from early-stage trial for lead asset - MSN
Tectonic Therapeutic (NASDAQ:TECX) Shares Gap Up Following Insider Buying Activity - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Director Timothy A. Springer Buys 129,294 Shares - MarketBeat
Tectonic Therapeutic director Timothy Springer buys $39.9 million in stock - MSN
Tectonic Therapeutic (NASDAQ:TECX) Trading Down 3.2%Should You Sell? - MarketBeat
Daniel Lochner Acquires 4,617 Shares of Tectonic Therapeutic (NASDAQ:TECX) Stock - MarketBeat
Contrasting Tectonic Therapeutic (NASDAQ:TECX) and Vir Biotechnology (NASDAQ:VIR) - Defense World
Major Stock Purchases Signal Strong Confidence in Tectonic Therapeutic! - TipRanks
Tectonic Therapeutic Inc (TECX) Stock: A Review of the Recent Movement - The News Heater
Tectonic Therapeutic director Timothy Springer buys $39.9 million in stock By Investing.com - Investing.com UK
Petri Dish: VC firm's new $340M seed fund; Watertown biotech raises $185M - The Business Journals
Brokerages Set Tectonic Therapeutic (NASDAQ:TECX) Target Price at $80.50 - Defense World
Tectonic announces ~$185M capital raise - MSN
Tectonic: Expansion Of TX45 Candidate Possible After Positive Interim Data (NASDAQ:TECX) - Seeking Alpha
Tectonic Therapeutic (NASDAQ:TECX) Given New $112.00 Price Target at Wells Fargo & Company - MarketBeat
TECX (Tectonic Therapeutic Inc) may reap gains as insiders became active recently - Knox Daily
Tectonic Therapeutic (NASDAQ:TECX) Stock Price Up 6.7% Following Analyst Upgrade - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Reaches New 52-Week HighTime to Buy? - MarketBeat
Tectonic secures $185 million in private equity funding - MSN
Tectonic Therapeutic to Raise $185 Million Via Private Investment in Public Equity Financing - Marketscreener.com
Tectonic Therapeutic Secures $185 Million in PIPE Deal - TipRanks
Tectonic Therapeutic announces $185M private placement - TipRanks
Tectonic Announces $185 Million Private Placement - The Manila Times
Tectonic secures $185 million in private equity funding By Investing.com - Investing.com UK
Tectonic Therapeutic, Inc. Announces $185 Million Private Investment in Public Equity Financing - Nasdaq
Tectonic Therapeutic (NASDAQ:TECX) Receives Consensus Rating of "Buy" from Analysts - MarketBeat
Major Funding Alert: Tectonic Therapeutic Lands $185M from Elite Investors at Premium Price - StockTitan
Tectonic Therapeutic (NASDAQ:TECX) Price Target Raised to $112.00 - Defense World
Tectonic Therapeutic reports ‘positive’ data from Phase 1b trial for TX45 - TipRanks
Tectonic Therapeutic (NASDAQ:TECX) Trading Down 13.3%Should You Sell? - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Stock Price Down 13.3%Here's What Happened - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Shares Up 6.7% on Analyst Upgrade - Defense World
Wall Street Rally: Dow Hits One-Month High as IBM Surges, Microsoft Declines – Market - HPBL
Tectonic’s Plates Shift On Positive Phase Ib PH-HFpEF Data - News & Insights
Tectonic Therapeutic Inc Stock (TECX) Financials Data
There is no financial data for Tectonic Therapeutic Inc (TECX). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.27%
3.05%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):